SLE inflammatory musculoskeletal abnormalities, confirmed by MRI, show a specific profile with a worse health-related quality of life.

Objectives: To determine if there is a clinicodemographic or serological profile associated with MRI-confirmed inflammatory musculoskeletal abnormalities in SLE patients. To investigate the relationship between these alterations and HRQoL.

Methods: patients with SLE from our previous study in whom a wrist and hand MRI with contrast was performed were included. Sociodemographic, clinical, therapeutic, serological data and PROs were collected and correlated with MRI findings.

Results: 83 patients were analysed. Erosions and synovitis were more common in older patients (55 ± 12.61 vs 45.06 ± 12.18 years, .001, 52.78 ± 12.99 vs 44.95 ± 12.49 years, .011). Synovitis was less frequent in patients with nephritis (6.7% vs 24.3%, .031). Treatment received showed some associations: patients with bone edema received more methotrexate (25% vs 6.3%, .033), those with erosions and peritendonitis received less mycophenolic acid (5.6% vs 22.9%, .034; 0% vs 12.8%, .026). Peritendonitis correlated with higher SLEDAI-2K (7 ± 2.45 vs 3.64 ± 3.34, .018).

Worse Haq: Patients with synovitis, tenosynovitis, peritendonitis and bone edema reported higher pain (6.03 ± 2.57 vs 4.26 ± 2.49, .005; 6.56 ± 1.95 vs 4.76 ± 2.75, .017; 8.80 ± 1.30 vs 4.95 ± 2.55, .001; 6.47 ± 2.62 vs 4.83 ± 2.58, .026, respectively). Patients with synovitis reported higher fatigue numerical values (2.32 ± 0.82 vs 1.91 ± 0.84, .035), with tenosynovitis worse FSS-9 (61.50 ± 1.73 vs 45.70 ± 16.80, .015), and with both synovitis and peritendonitis worse HAQ (1.14 ± 0.69 vs 0.75 ± 0.65, .031; 1.69 ± 0.07 vs 0.90 ± 0.69, .018).

Conclusion: SLE patients with confirmed musculoskeletal alterations on MRI were generally older, less likely to have lupus nephritis, and received different treatments. They reported a worse HRQoL in terms of pain, fatigue and functional disability.